![Shirley Hollander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 467 065 $ au 31/05/2026
Shirley Winkler Hollander is Chief Financial Officer & Executive Director at iFOREX Financial Trading Holdings Ltd. starting in 2025.
Former roles include Finance Director at Stk Bio-Ag Technologies from 2021 to 2024, Associate Director-Accounting at Teva Pharmaceuticals Ltd. (Israel) from 2017 to 2021, and Assurance Manager at Ernst & Young (Israel) Ltd. from 2010 to 2017.
Education includes an undergraduate degree from Ben-Gurion University of the Negev.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,78% | 16/03/2026 | 175 000 ( 0,78% ) | 467 065 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
Stk Bio-Ag Technologies | Directeur Financier/CFO | 01/07/2024 |
Teva Pharmaceuticals Ltd. (Israel) | Comptroller/Controller/Auditor | 01/06/2021 |
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01/09/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young (Israel) Ltd.
Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Stk Bio-Ag Technologies | |
Teva Pharmaceuticals Ltd. (Israel) |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
